Trial Profile

A Multicenter, Open-label, Uncontrolled, Long-term Trial to Assess the Safety and Efficacy of ETC-1002 in Patients With Hyper-LDL Cholesterolemia

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 15 Apr 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Bempedoic acid (Primary)
Indications Hypercholesterolaemia
Focus Adverse reactions; Registrational; Therapeutic Use
Sponsors Otsuka Pharmaceutical

Most Recent Events

09 Apr 2025 Status changed from active, no longer recruiting to completed.
13 Dec 2023 Planned End Date changed from 1 Oct 2024 to 31 Oct 2024.
13 Dec 2023 Planned primary completion date changed from 1 Oct 2024 to 31 Oct 2024.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com